Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Inclusion Criteria: * Subjects aged \>= 18 years * Females of child bearing potential must have a negative urine pregnancy test prior to entry into the study * Patients with suspected or confirmed heparin-induced thrombocytopenia Type II, with or without ongoing thrombosis who require parenteral anticoagulation * Signed written informed consent by the subject, or if the subject is unable to do so, consent will be sought from their family member, or a trusted person nominated by the subject or the legal representative Exclusion Criteria: * Uncontrolled bleeding * Severe hepatic impairment (Child-Pugh Class C) * Hypersensitivity to argatroban or to any of the excipients (sorbitol and ethanol) * Pregnancy (exclusion by routine urine test) * Lactating woman